Key Record Dates
ClinicalTrials.gov Identifier: | NCT05482074 |
---|---|
Brief Title: | Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2 |
First Submitted : | July 27, 2022 |
First Submitted that Met QC Criteria : | July 29, 2022 |
First Posted : | August 1, 2022 |
Last Update Submitted that Met QC Criteria : | January 18, 2024 |
Last Update Posted : | January 19, 2024 |